EW - Edwards Lifesciences down 14% on lower 2024 sales growth for transcatheter valves
2024-07-24 16:55:55 ET
More on Edwards Lifesciences
- Edwards Lifesciences: Focus On The Heart
- Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
- Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
- Edwards Lifesciences Q2 2024 Earnings Preview
- Edwards Lifesciences acquires early-stage TMVR company Innovalve